Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
Gross Profit Growth Accelerating
Trending higher, above historical average, slight contraction.
Left:
||||
Year-over-year gross profit growth rate
Latest
14.05%
↑ 123% above average
Average (39q)
6.30%
Historical baseline
Range
High:88.71%
Low:-27.71%
CAGR
-4.6%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 14.05% |
| Q2 2025 | 1.45% |
| Q1 2025 | -1.61% |
| Q4 2024 | -15.00% |
| Q3 2024 | 7.12% |
| Q2 2024 | 9.02% |
| Q1 2024 | -9.21% |
| Q4 2023 | -11.31% |
| Q3 2023 | 49.03% |
| Q2 2023 | -1.49% |
| Q1 2023 | 3.75% |
| Q4 2022 | 21.63% |
| Q3 2022 | -7.65% |
| Q2 2022 | 13.49% |
| Q1 2022 | -0.73% |
| Q4 2021 | 9.87% |
| Q3 2021 | 8.04% |
| Q2 2021 | 5.41% |
| Q1 2021 | 22.03% |
| Q4 2020 | 0.89% |
| Q3 2020 | 10.04% |
| Q2 2020 | -9.90% |
| Q1 2020 | 10.31% |
| Q4 2019 | -5.31% |
| Q3 2019 | 8.85% |
| Q2 2019 | 4.80% |
| Q1 2019 | -10.91% |
| Q4 2018 | 18.55% |
| Q3 2018 | 11.87% |
| Q2 2018 | 53.31% |
| Q1 2018 | -17.10% |
| Q4 2017 | -0.30% |
| Q3 2017 | -22.83% |
| Q2 2017 | 17.17% |
| Q1 2017 | 14.36% |
| Q4 2016 | -27.71% |
| Q3 2016 | -12.93% |
| Q2 2016 | 27.36% |
| Q1 2016 | -24.93% |
| Q4 2015 | 88.71% |